Atlas Trials

Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

Clinical trial NCT00138840 · COMPLETED

Trial details

NCT number
NCT00138840
Sponsor
Synta Pharmaceuticals Corp.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2005-08-01
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.